FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
JPMorgan analyst Anupam Rama reiterated an Overweight rating and $79.00 price target on Apellis Pharmaceuticals (NASDAQ: APLS).
The analyst comments "The quarter was highlighted by a 1Q24 beat for Syfovre, though we suspect the call will largely focus on near-term GA market dynamics post... More

